Laddar...
CCL3 and CCL4 are biomarkers for BCR pathway activation and prognostic serum markers in diffuse large B cell lymphoma (DLBCL)
B cell receptor (BCR) signalling is an important pathway in diffuse large B cell lymphoma (DLBCL). In response to BCR triggering, normal and malignant B cells secrete the chemokines CCL3 and CCL4 to attract accessory cells to the tissue microenvironment. We measured CCL3 and CCL4 serum concentration...
Sparad:
| I publikationen: | Br J Haematol |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4715651/ https://ncbi.nlm.nih.gov/pubmed/26358140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13659 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|